EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography

Pietro G Lacaita, Thomas Senoner, Valentin Bilgeri, Stefan Rauch, Fabian Barbieri, Benedikt Kindl, Fabian Plank, Wolfgang Dichtl, Johannes Deeg, Gerlig Widmann, Gudrun M Feuchtner

European Radiology · 2024

DOI: 10.1007/s00330-024-11061-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Pietro G Lacaita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Medical University Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Adipose Tissue, Pericardium, Lipomatosis, Computed Tomography Angiography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Novel pericardial adipose tissue imaging biomarkers are currently under investigation for cardiovascular risk stratification. However, a specific compartment of the epicardial adipose tissue (EAT), lipomatous hypertrophy of the interatrial septum (LHIS), is included in the pericardial fat volume (PCFV) quantification software. Our aim was to evaluate LHIS by computed tomography angiography (CTA), to elaborate differences to other pericardial adipose tissue components (EAT) and paracardial adipose tissue (PAT), and to compare CT with [ 18 F]FDG-PET. Materials and methods Of 6983 patients screened who underwent coronary CTA for clinical indications, 190 patients with LHIS were finally included (age 62.8 years ± 9.6, 31.6% females, BMI 28.5 kg/cm 2 ± 4.7) in our retrospective cohort study. CT images were quantified for LHIS, EAT, and PAT density (HU), and total PCFV, with and without LHIS, was calculated. CT was compared with [ 18 F]FDG-PET if available.

Results

CT-density of LHIS was higher (− 22.4 HU ± 22.8) than all other pericardial adipose tissue components: EAT right and left (97.4 HU ± 13 and − 95.1 HU ± 13) PAT right and left (− 107.5 HU ± 13.4 and − 106.3 HU ± 14.5) and PCFV density −83.3 HU ± 5.6 ( p < 0.001). There was a mild association between LHIS and PAT right (Beta 0.338, p = 0.006, 95% CI: 0.098–577) and PAT left (Beta 0.249, p = 0.030; 95% CI: 0.024–0.474) but not EAT right ( p = 0.325) and left ( p = 0.351), and not with total PCFV density ( p = 0.164). The segmented LHIS volume comprised 3.01% of the total PCFV, and 4.3% (range, 2.16–11.7%) in those with LHIS > 9 mm. [ 18 F]FDG-PET: LHIS was tracer uptake positive in 83.3% (37.5%: mild and 45.8%: minimal) of 24 patients.

Conclusions

LHIS is a distinct compartment of PCFV with higher density suggesting brown fat and has no consistent association with EAT, but rather with PAT. Clinical relevance statement LHIS should be recognized as a distinct compartment of the EAT, when using EAT for cardiovascular risk stratification. Key Points LHIS is currently included in EAT quantification software . LHIS density is relatively high, it is not associated with EAT, and has a high [ 18 F]FDG-PET positive rate suggesting brown fat . LHIS is a distinct compartment of the EAT, and it may act differently as an imaging biomarker for cardiovascular risk stratification .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose TissuePericardiumLipomatosisComputed Tomography AngiographyTomography, X-Ray ComputedAtrial SeptumHumansFemaleMiddle AgedMaleRetrospective StudiesFluorodeoxyglucose F18BiomarkersAgedHypertrophyPositron-Emission TomographyRadiopharmaceuticals

Stichwörter der Autor:innen

Adipose tissueBiomarkersComputed tomography angiographyLipomatous hypertrophy of the interatrial septumPericardium

Substanzen

Fluorodeoxyglucose F18BiomarkersRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, Medical University Innsbruck, Innsbruck, Austria.
  • Department of Anaesthesiology and Intensive Care, Medical University Innsbruck, Innsbruck, Austria.
  • Department of Internal Medicine, Cardiology, Medical University Innsbruck, Innsbruck, Austria.
  • Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany.
  • Department of Internal Medicine, Tyrol Clinicum Hall, Hall, Austria.

Zitieren

APA

Lacaita, P. G., Senoner, T., Bilgeri, V., Rauch, S., Barbieri, F., Kindl, B., Plank, F., Dichtl, W., Deeg, J., Widmann, G., & Feuchtner, G. M. (2024). The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography. European Radiology. https://doi.org/10.1007/s00330-024-11061-3

Vancouver

Lacaita PG, Senoner T, Bilgeri V, Rauch S, Barbieri F, Kindl B, et al. The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography. European Radiology. 2024. doi:10.1007/s00330-024-11061-3

BibTeX
@article{Lacaita2024,
  author = {Lacaita, Pietro G and Senoner, Thomas and Bilgeri, Valentin and Rauch, Stefan and Barbieri, Fabian and Kindl, Benedikt and Plank, Fabian and Dichtl, Wolfgang and Deeg, Johannes and Widmann, Gerlig and Feuchtner, Gudrun M},
  title = {The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography},
  journal = {European Radiology},
  year = {2024},
  doi = {10.1007/s00330-024-11061-3}
}
Kostenlos starten →